EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines

Anna-Lise Williamson iD

Viruses · 2025

DOI: 10.3390/v17020186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Anna-Lise Williamson. Beteiligte Einrichtung: Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa. Hauptthemen laut MEDLINE: Monkeypox virus, Mpox, Monkeypox, Smallpox Vaccine, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, there are two major poxvirus outbreaks: mpox, caused by the monkeypox virus, and lumpy skin disease, caused by the lumpy skin disease virus. While vaccines for both diseases exist, there is a need for improved vaccines. The original vaccines used to eradicate smallpox, which also protect from the disease now known as mpox, are no longer acceptable. This is mainly due to the risk of serious adverse events, particularly in HIV-positive people. The next-generation vaccine for mpox prevention is modified vaccinia Ankara, which does not complete the viral replication cycle in humans and, therefore, has a better safety profile. However, two modified vaccinia Ankara immunizations are needed to give good but often incomplete protection, and there are indications that the immune response will wane over time. A better vaccine that induces a long-lived response with only one immunization is desirable. Another recently available smallpox vaccine is LC16m8. While LC16m8 contains replicating vaccinia virus, it is a more attenuated vaccine than the original vaccines and has limited side effects. The commonly used lumpy skin disease vaccines are based on attenuated lumpy skin disease virus. However, an inactivated or non-infectious vaccine is desirable as the disease spreads into new territories. This article reviews novel vaccine approaches, including mRNA and subunit vaccines, to protect from poxvirus infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monkeypox virusMpox, MonkeypoxSmallpox VaccineViral VaccinesCapripoxvirusLumpy Skin DiseaseAnimalsHumansVaccinia virusVaccines, AttenuatedVaccinationVaccine Development

Stichwörter der Autor:innen

LSDVmpox: lumpy skin diseasepoxvirusvaccines

Substanzen

Smallpox VaccineViral VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa.
  • Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town 7925, South Africa.

ORCID-Profile: Anna-Lise Williamson

Zitieren

APA

Williamson, A. L. (2025). Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines. Viruses. https://doi.org/10.3390/v17020186

Vancouver

Williamson AL. Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines. Viruses. 2025. doi:10.3390/v17020186

BibTeX
@article{Williamson2025,
  author = {Williamson, Anna-Lise},
  title = {Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020186}
}
Kostenlos starten →